Patents Assigned to Terragen Discovery Inc.
  • Patent number: 6455270
    Abstract: Lichen-derived organic acids such as vulpinic acid and usnic acid have been found to be effective inhibitors of eukaryotic protein kinase activity. Thus, eukaryotic protein kinase activity present in a sample or organism can be inhibited by adding to the sample or organism an effective inhibitory amount of a lichen-derived organic acid.
    Type: Grant
    Filed: October 16, 2000
    Date of Patent: September 24, 2002
    Assignee: TerraGen Discovery Inc.
    Inventors: Julian E. Davies, Barbara Waters, Geeta Saxena
  • Patent number: 6242211
    Abstract: The present invention relates to a novel drug discovery system for generating molecular diversity. The system provides methods for subjecting the genetic materials from a plurality of species of organisms to homologous or homeologous recombination to create novel genes and metabolic pathways. The recombined genetic materials are cloned to form recombined combinatorial gene expression libraries. Methods for screening such gene expression libraries containing recombined genes and metabolic pathways for novel activities and compounds are also provided.
    Type: Grant
    Filed: March 5, 1999
    Date of Patent: June 5, 2001
    Assignee: Terragen Discovery, Inc.
    Inventors: Todd C. Peterson, Paul Brian
  • Patent number: 6197811
    Abstract: A compound selected from the group consisting of a 5,6-dihydro-&agr;-pyrone of formula (I): wherein bond a is oriented either or ; X is O or NH; R1 is selected from the group consisting of: a group R3(O)C— wherein R3 is selected from the group consisting of: (i) a group of formula R4—CH═CH— wherein R4 is C1-C20 alkyl, C2-C20 alkenyl, an aryl group, or a 5- or 6-membered unsaturated heterocyclic ring containing one or two O, N or S atoms, (ii) C2-C20 alkyl; and (iii) an aryl group or a substituent which is a fused ring system of formula (1) or (2):  wherein each of R′ and R″, which are the same or different and may occupy any position on ring a or ring b of said fused ring system, is H or C1-C6 alkyl; a group ArCH2— wherein Ar is an aryl group; and a group R5O—CH2— wherein R5 is C1-C6 alkyl optionally interrupted by one or two O atoms; and R2 is CH3 or, when R1 is a group of formula (A) as defined below, R2 i
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: March 6, 2001
    Assignees: Terragen Discovery Inc., Suntory Limited
    Inventors: Martin A. Hayes, David J. Hardick, Jenny S. Tang, Hamish Ryder, Adrian J. Folkes, Toshio Tatsuoka, Masashi Matsui
  • Patent number: 6132984
    Abstract: Lichen-derived organic acids such as vulpinic acid and usnic acid have been found to be effective inhibitors of eukaryotic protein kinase activity. Thus, eukaryotic protein kinase activity present in a sample or organism can be inhibited by adding to the sample or organism an effective inhibitory amount of a lichen-derived organic acid.
    Type: Grant
    Filed: October 16, 1998
    Date of Patent: October 17, 2000
    Assignee: TerraGen Discovery Inc.
    Inventors: Julian E. Davies, Barbara Waters, Geeta Saxena